Clinical Trial Update: Desmoteplase in Acute Ischemic Stroke (DIAS) [Phase 2]

View source ↗

Summary

Phase 2 trial update for Desmoteplase in acute ischemic stroke has completed enrollment. The update presents results from the DIAS program.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Desmoteplase (Desmoteplase)

Snippet

Sponsor: PAION Deutschland GmbH | Conditions: Stroke | Phase 2 | Status: COMPLETED